Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 154
- Registration Number
- NCT06532565
- Locations
- 🇺🇸
Stanford Cancer Center, Palo Alto, California, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸NEXT Oncology, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath